Related Experiment Video
Updated: Apr 27, 2026

Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration
Published on: June 7, 2014
Ischemia-reperfusion: From cell biology to acute kidney injury
N Chatauret1, L Badet2, B Barrou2
1INSERM, U1087, Ischémie-reperfusion en transplantation d'organe : mécanismes et innovations thérapeutiques, Poitiers ; université de Poitiers, faculté de Médecine et de Pharmacie, 86021 Poitiers, France; CHU de Poitiers, Laboratoire de biochimie, 86021 Poitiers, France.
Abstract:
Ischemia reperfusion injury occurs in the kidney when blood supply is interrupted in clinical settings such as kidney transplantation or nephron sparing surgery for renal tumors. These lesions lead to acute kidney injury (AKI) a detrimental situation associated with impaired short-term allograft function (delayed graft function or primary non function) but also long-term transplant survival through the onset of chronic allograft nephropathy. The present review details the cellular and molecular consequences of ischemia reperfusion in a native kidney as well as in a kidney graft after cold ischemia time, giving a comprehensive description of biological pathways involved during the phase of ischemia and during the reperfusion period where the rapid return to normoxia leads to a large burst of reactive oxygen species along with a dramatic reduction in antioxidant defenses. This work also focuses on the distinct susceptibilities of kidney cells to ischemia (endothelial vs epithelial) and the outcome of acute kidney injury.
Insights
Ischemia reperfusion injury in kidneys, common in transplants, causes acute kidney injury (AKI). This review details the cellular and molecular events during ischemia and reperfusion, impacting kidney function and transplant survival.
Area of Science:
- Nephrology
- Transplantation immunology
- Cellular and molecular medicine
Background:
- Ischemia reperfusion injury (IRI) is a critical complication in kidney transplantation and surgery.
- IRI leads to acute kidney injury (AKI), impairing both short-term graft function and long-term transplant survival.
- Chronic allograft nephropathy is a significant long-term consequence of IRI.
Purpose of the Study:
- To review the cellular and molecular mechanisms of kidney IRI.
- To describe the biological pathways activated during ischemia and reperfusion.
- To highlight the differential susceptibility of kidney cells to ischemic injury.
Main Methods:
- Literature review of cellular and molecular events in kidney IRI.
- Analysis of biological pathways involved in ischemia and reperfusion phases.
- Examination of distinct kidney cell responses (endothelial vs. epithelial) to ischemia.
Main Results:
- Reperfusion following ischemia causes a surge in reactive oxygen species and depleted antioxidant defenses.
- Kidney cells exhibit varying susceptibility to ischemic damage, with distinct endothelial and epithelial responses.
- AKI resulting from IRI has profound implications for kidney allograft outcomes.
Conclusions:
- Understanding the molecular basis of kidney IRI is crucial for improving transplant success.
- Targeting cellular responses during ischemia and reperfusion may mitigate AKI and enhance graft survival.
- Further research into differential cell susceptibility can inform therapeutic strategies for kidney protection.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury V: Interprofessional Care
Cellular Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations

